Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Drug Store Chain Growell Launches Takeover Bid For Terashima

This article was originally published in PharmAsia News

Executive Summary

Japanese drug store chain Growell Holdings launches a takeover bid for Terashima, a Tsukuba-based drug store chain with around 100 stores. Growell plans to acquire 50.18 percent of Terashima's outstanding shares and take the company as a subsidiary after the deal. Terashima President Takao Terashima was approached by Growell and the two sides started negotiations in August. Growell was established by a merger of Welcia Kanto and Takada Yakyoku. Japanese retailer Aeon Group is the largest share holder of both Growell and Terashima. (Click here for more - Japanese language

You may also be interested in...



P&G Tapping Into UK Vegan Trend Via Nature’s Best

Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement. 

UK Shares How Its Medtech Regs Already Diverge From The EU: COVID-19 Marks The Start

The MHRA has updated its guidance on regulatory flexibilities for medical devices and medicinal products resulting from COVID-19 to highlight how its approach differs from the EU.

Carag Applies Bioabsorbable Material Technology To Transseptal Occluders

The Swiss company is planning a US trial of CBSO, the first transcatheter septal occluder with a bioresorbable, metal-free frame.

UsernamePublicRestriction

Register

LL1127945

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel